HomeInsightsPE

Bharat Immunological & Biological Corporation Ltd PE Ratio

Bharat Immunological & Biological Corporation Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

57.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

PE

-

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd is 0 as of 24 Nov 15:30 PM .
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2019 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 23.62 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Bharat Immunological & Biological Corporation Ltd

No data available

Company Fundamentals for Bharat Immunological & Biological Corporation Ltd

No data available

Image

Bharat Immunological & Biological Corporation Ltd

NSE: BHARATIMMUNOLOG

Share Price

₹ 23.62

0.56 (2.43%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Bharat Immunological & Biological Corporation Ltd

1M

1Y

3Y

5Y

Monitoring Bharat Immunological & Biological Corporation Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202423.62
21 Nov 202423.06
19 Nov 202423.78
18 Nov 202423.33
14 Nov 202423.32
13 Nov 202423.51
12 Nov 202424.81
11 Nov 202425.22
08 Nov 202425.25
07 Nov 202425.91

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bharat Immunological & Biological Corporation Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Bharat Immunological & Biological Corporation Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Revenue of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical EBITDA of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Net Profit of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bharat Immunological & Biological Corporation Ltd

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

2024-08-10 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bharat Immunological & Biological Corporation Ltd

What is the current PE Ratio of Bharat Immunological & Biological Corporation Ltd?

The Current PE Ratio of Bharat Immunological & Biological Corporation Ltd is 0.0 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Bharat Immunological & Biological Corporation Ltd last year?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Bharat Immunological & Biological Corporation Ltd indicate about its stock?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Bharat Immunological & Biological Corporation Ltd.

What is the PE Ratio Growth of Bharat Immunological & Biological Corporation Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bharat Immunological & Biological Corporation Ltd grew by -% whereas, the EPS ratio grew by 7.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*